| Previous Close | 2.2568 |
| Open | 2.4400 |
| Bid | 0.0000 x 1200 |
| Ask | 0.0000 x 800 |
| Day's Range | 2.3200 - 2.4552 |
| 52 Week Range | 1.4300 - 3.9400 |
| Volume | 13,618 |
| Avg. Volume | 2,974 |
| Market Cap | 11.278M |
| Beta (3Y Monthly) | 1.34 |
| PE Ratio (TTM) | 3.87 |
| EPS (TTM) | 0.6000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.00 |
NEW YORK, Nov. 21, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
RAMAT GAN , Israel , Nov. 01, 2018 /PRNewswire/ -- TL Biopharmaceuticals Ltd. (NASDAQ: XTLB) (TASE: XTLB.TA) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company developing ...
RAMAT GAN , Israel , July 24, 2018 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) (TASE: XTLB.TA) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company ...
RAMAT GAN , Israel , May 29, 2018 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) (TASE: XTLB.TA) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company ...